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Background: Enhanced attention has focused on contrast induced nephropathy among patients undergoing PCI. This study reports three year 
trends in the rate of renal complications among Medicare Beneficiaries (MB) undergoing PCI.
Methods: A retrospective analysis was conducted using annual MedPar data files for fiscal years (FY) 2006 through 2008. The study sample 
consists of 1,108,222 Medicare Beneficiaries (MB) undergoing a PCI without CABG or valve surgery. ICD-9-CM procedure and diagnosis codes were 
used to identify the outcomes of interest as well as the co-morbidities for risk-adjustment. PCI hospitalizations were reported as either elective PCI 
or PCI with primary STEMI or cardiogenic shock. Separate multivariate logistic regression models were estimated to calculate annual risk-adjusted 
outcomes ((expected rate - observed rate) + the mean of the subset population).
Results: The table indicates that MBs in both sub-populations were more likely to experience each of the risk-adjusted renal outcomes reported 
during FY-2008 than FY-2006 or FY-2007. For example, MBs were 1.7 times more likely to experience new onset hemodialysis in FY-2008 compared 
to FY-2006 in the elective PCI group.
Conclusion: The current trends in renal complications suggest the current focus on contrast induced nephropathy to reduce renal complications is 
warranted among MB. 
2006 2007 2008
Elective PCI
Medicare Beneficiaries 344.944 303,302 312,377
Observed Acute Renal Failure (ARF) 2.87% 3.39% 4.55%
Risk-adjusted ARF 3.28% 3.15% 4.32%
Observed New Onset Hemodialysis 0.53% 0.52% 0.86%
Risk-Adjusted New Onset Hemodialysis 0.50% 0.57% 0.86%
Observed Mortality Rate 0.78% 0.81% 1.02%
Risk-adjusted Mortality Rate 0.80% 0.77% 1.03%
Non-elective PCI (Primary STEMI or Cardiogentic Shock)
Medicare Beneficiaries 50,274 46,620 50,705
Observed Acute Renal Failure (ARF) 7.13% 7.93% 9.77%
Risk-adjusted ARF 7.55% 7.64% 9.62%
Observed New Onset Hemodialysis 0.33% 0.41% 0.52%
Risk-Adjusted New Onset Hemodialysis 0.37% 0.38% 0.50%
Observed Mortality Rate 7.38% 7.56% 7.24%
Risk-adjusted Mortality Rate 7.62% 8.15% 6.46%
